O	0	9	Proteomic	Proteomic	JJ	B-NP
O	10	20	comparison	comparison	NN	I-NP
O	21	23	of	of	IN	B-PP
B-Cell	24	38	nasopharyngeal	nasopharyngeal	JJ	B-NP
I-Cell	39	45	cancer	cancer	NN	I-NP
I-Cell	46	50	cell	cell	NN	I-NP
I-Cell	51	56	lines	line	NNS	I-NP
I-Cell	57	61	C666	C666	NN	B-NP
I-Cell	61	62	-	-	HYPH	B-NP
I-Cell	62	63	1	1	CD	I-NP
O	64	67	and	and	CC	O
B-Cell	68	72	NP69	NP69	NN	B-NP
O	73	83	identifies	identify	VBZ	B-VP
O	84	88	down	down	RB	B-ADVP
O	88	89	-	-	HYPH	B-NP
O	89	99	regulation	regulation	NN	I-NP
O	100	102	of	of	IN	B-PP
O	103	110	annexin	annexin	NN	B-NP
O	111	113	II	II	CD	I-NP
O	114	117	and	and	CC	I-NP
O	118	123	beta2	beta2	NN	I-NP
O	123	124	-	-	HYPH	B-NP
O	124	131	tubulin	tubulin	NN	I-NP
O	132	135	for	for	IN	B-PP
B-Cancer	136	150	nasopharyngeal	nasopharyngeal	JJ	B-NP
I-Cancer	151	160	carcinoma	carcinoma	NN	I-NP
O	160	161	.	.	.	O

O	163	170	CONTEXT	CONTEXT	NN	B-NP
O	170	171	:	:	:	O
B-Cancer	172	186	Nasopharyngeal	Nasopharyngeal	JJ	B-NP
I-Cancer	187	196	carcinoma	carcinoma	NN	I-NP
O	197	198	(	(	(	O
B-Cancer	198	201	NPC	NPC	NN	B-NP
O	201	202	)	)	)	O
O	202	203	,	,	,	O
O	204	210	common	common	JJ	B-ADJP
O	211	213	in	in	IN	B-PP
O	214	222	southern	southern	JJ	B-NP
O	223	228	China	China	NNP	I-NP
O	229	232	and	and	CC	O
O	233	238	North	North	NNP	B-NP
O	239	245	Africa	Africa	NNP	I-NP
O	245	246	,	,	,	O
O	247	250	has	have	VBZ	B-VP
O	251	252	a	a	DT	B-NP
O	253	260	complex	complex	JJ	I-NP
O	261	269	etiology	etiology	NN	I-NP
O	270	279	involving	involve	VBG	B-VP
O	280	289	interplay	interplay	NN	B-NP
O	290	297	between	between	IN	B-PP
O	298	303	viral	viral	JJ	B-NP
O	303	304	,	,	,	I-NP
O	305	318	environmental	environmental	JJ	I-NP
O	318	319	,	,	,	O
O	320	323	and	and	CC	O
O	324	334	hereditary	hereditary	JJ	B-NP
O	335	342	factors	factor	NNS	I-NP
O	343	346	and	and	CC	O
O	347	349	is	be	VBZ	B-VP
O	350	356	almost	almost	RB	I-VP
O	357	367	constantly	constantly	RB	I-VP
O	368	378	associated	associate	VBN	I-VP
O	379	383	with	with	IN	B-PP
O	384	387	the	the	DT	B-NP
O	388	395	Epstein	Epstein	NNP	I-NP
O	395	396	-	-	HYPH	I-NP
O	396	400	Barr	Barr	NNP	I-NP
O	401	406	virus	virus	NN	I-NP
O	406	407	.	.	.	O

O	408	413	Since	Since	IN	B-SBAR
O	414	417	the	the	DT	B-NP
O	418	427	prognosis	prognosis	NN	I-NP
O	428	430	of	of	IN	B-PP
O	431	438	locally	locally	RB	B-NP
O	439	447	advanced	advanced	JJ	I-NP
O	448	451	and	and	CC	I-NP
B-Cancer	452	462	metastatic	metastatic	JJ	I-NP
I-Cancer	463	471	diseases	disease	NNS	I-NP
O	472	474	is	be	VBZ	B-VP
O	475	479	poor	poor	JJ	B-ADJP
O	479	480	,	,	,	O
O	481	490	increased	increase	VBN	B-NP
O	491	504	understanding	understanding	NN	I-NP
O	505	507	of	of	IN	B-PP
O	508	511	the	the	DT	B-NP
O	512	524	pathogenesis	pathogenesis	NN	I-NP
O	525	527	of	of	IN	B-PP
B-Cancer	528	531	NPC	NPC	NN	B-NP
O	532	537	would	would	MD	B-VP
O	538	540	be	be	VB	I-VP
O	541	550	important	important	JJ	B-ADJP
O	551	554	for	for	IN	B-PP
O	555	566	discovering	discover	VBG	B-VP
O	567	572	novel	novel	JJ	B-NP
O	573	580	markers	marker	NNS	I-NP
O	581	584	for	for	IN	B-PP
O	585	593	patients	patient	NNS	B-NP
O	593	594	'	'	POS	B-NP
O	595	605	management	management	NN	I-NP
O	605	606	.	.	.	O

O	607	617	OBJECTIVES	OBJECTIVES	NNS	B-NP
O	617	618	:	:	:	O
O	619	621	To	To	TO	B-VP
O	622	629	compare	compare	VB	I-VP
O	630	633	the	the	DT	B-NP
O	634	643	proteomic	proteomic	JJ	I-NP
O	644	654	expression	expression	NN	I-NP
O	655	662	profile	profile	NN	I-NP
O	663	670	between	between	IN	B-PP
O	671	673	an	an	DT	B-NP
O	674	681	Epstein	Epstein	NNP	I-NP
O	681	682	-	-	HYPH	I-NP
O	682	686	Barr	Barr	NNP	I-NP
O	687	692	virus	virus	NN	I-NP
O	692	693	-	-	HYPH	B-VP
O	693	703	associated	associate	VBN	B-NP
B-Cell	704	707	NPC	NPC	NN	I-NP
I-Cell	708	712	cell	cell	NN	I-NP
I-Cell	713	717	line	line	NN	I-NP
O	718	719	(	(	(	O
B-Cell	719	723	C666	C666	NN	B-NP
I-Cell	723	724	-	-	HYPH	B-NP
I-Cell	724	725	1	1	CD	I-NP
O	725	726	)	)	)	O
O	727	730	and	and	CC	O
O	731	732	a	a	DT	B-NP
O	733	739	normal	normal	JJ	I-NP
B-Cell	740	742	NP	NP	NN	I-NP
I-Cell	743	747	cell	cell	NN	I-NP
I-Cell	748	752	line	line	NN	I-NP
O	753	754	(	(	(	O
B-Cell	754	758	NP69	NP69	NN	B-NP
O	758	759	)	)	)	O
O	759	760	.	.	.	O

O	761	764	The	The	DT	B-NP
O	765	773	proteins	protein	NNS	I-NP
O	774	778	with	with	IN	B-PP
O	779	791	differential	differential	JJ	B-NP
O	792	802	expression	expression	NN	I-NP
O	803	807	were	be	VBD	B-VP
O	808	816	analyzed	analyze	VBN	I-VP
O	817	819	in	in	IN	B-PP
O	820	822	40	40	CD	B-NP
O	823	839	undifferentiated	undifferentiated	JJ	I-NP
B-Cancer	840	843	NPC	NPC	NN	I-NP
O	844	852	paraffin	paraffin	NN	I-NP
O	852	853	-	-	HYPH	B-NP
O	853	861	embedded	embed	VBN	I-NP
B-Tissue	862	871	specimens	specimen	NNS	I-NP
O	871	872	.	.	.	O

O	873	879	DESIGN	DESIGN	NN	B-NP
O	879	880	:	:	:	O
O	881	895	Differentially	Differentially	RB	B-NP
O	896	905	expressed	express	VBN	I-NP
O	906	914	proteins	protein	NNS	I-NP
O	915	925	discovered	discover	VBN	B-VP
O	926	933	between	between	IN	B-PP
O	934	937	the	the	DT	B-NP
O	938	941	two	two	CD	I-NP
B-Cell	942	946	cell	cell	NN	I-NP
I-Cell	947	952	lines	line	NNS	I-NP
O	953	957	were	be	VBD	B-VP
O	958	968	identified	identify	VBN	I-VP
O	969	971	by	by	IN	B-PP
O	972	976	mass	mass	NN	B-NP
O	977	989	spectrometry	spectrometry	NN	I-NP
O	989	990	.	.	.	O

O	991	996	After	After	IN	B-PP
O	997	1009	confirmation	confirmation	NN	B-NP
O	1010	1012	by	by	IN	B-PP
O	1013	1031	immunocytochemical	immunocytochemical	JJ	B-NP
O	1032	1040	staining	staining	NN	I-NP
O	1040	1041	,	,	,	O
O	1042	1047	their	their	PRP$	B-NP
O	1048	1058	expression	expression	NN	I-NP
O	1059	1061	in	in	IN	B-PP
O	1062	1069	patient	patient	NN	B-NP
B-Tissue	1070	1077	samples	sample	NNS	I-NP
O	1078	1081	was	be	VBD	B-VP
O	1082	1090	measured	measure	VBN	I-VP
O	1091	1096	using	use	VBG	B-VP
O	1097	1099	40	40	CD	B-NP
O	1100	1105	pairs	pair	NNS	I-NP
O	1106	1108	of	of	IN	B-PP
O	1109	1125	undifferentiated	undifferentiated	JJ	B-NP
B-Cell	1126	1130	NPCs	NPC	NNS	I-NP
O	1131	1139	together	together	RB	B-ADVP
O	1140	1144	with	with	IN	B-PP
O	1145	1150	their	their	PRP$	B-NP
O	1151	1159	adjacent	adjacent	JJ	I-NP
O	1160	1166	normal	normal	JJ	I-NP
B-Tissue	1167	1176	epithelia	epithelia	NN	I-NP
O	1176	1177	.	.	.	O

O	1178	1185	RESULTS	RESULTS	NNS	B-NP
O	1185	1186	:	:	:	O
O	1187	1196	Proteomic	Proteomic	JJ	B-NP
O	1197	1205	findings	finding	NNS	I-NP
O	1206	1215	indicated	indicate	VBD	B-VP
O	1216	1220	that	that	IN	B-SBAR
O	1221	1230	adenosine	adenosine	NN	B-NP
O	1231	1243	triphosphate	triphosphate	NN	I-NP
O	1244	1252	synthase	synthase	NN	I-NP
O	1253	1258	alpha	alpha	NN	I-NP
O	1259	1264	chain	chain	NN	I-NP
O	1265	1268	was	be	VBD	B-VP
O	1269	1271	up	up	RB	B-ADVP
O	1271	1272	-	-	HYPH	B-NP
O	1272	1281	regulated	regulate	VBN	B-VP
O	1281	1282	,	,	,	O
O	1283	1290	whereas	whereas	IN	O
O	1291	1298	annexin	annexin	NN	B-NP
O	1299	1301	II	II	CD	I-NP
O	1301	1302	,	,	,	O
O	1303	1310	annexin	annexin	NN	B-NP
O	1311	1312	V	V	NN	I-NP
O	1312	1313	,	,	,	O
O	1314	1318	beta	beta	NN	B-NP
O	1318	1319	(	(	(	O
O	1319	1320	2	2	CD	B-NP
O	1320	1321	)	)	)	O
O	1321	1322	-	-	HYPH	B-NP
O	1322	1329	tubulin	tubulin	NN	I-NP
O	1329	1330	,	,	,	O
O	1331	1334	and	and	CC	O
O	1335	1343	profilin	profilin	NN	B-NP
O	1344	1345	1	1	CD	I-NP
O	1346	1350	were	be	VBD	B-VP
O	1351	1355	down	down	RB	B-ADVP
O	1355	1356	-	-	HYPH	B-NP
O	1356	1365	regulated	regulate	VBN	B-VP
O	1365	1366	.	.	.	O

O	1367	1372	After	After	IN	B-PP
O	1373	1383	confirming	confirm	VBG	B-VP
O	1384	1387	the	the	DT	B-NP
O	1388	1395	results	result	NNS	I-NP
O	1396	1398	in	in	IN	B-PP
O	1399	1403	agar	agar	NN	B-NP
O	1403	1404	-	-	HYPH	O
O	1404	1413	processed	process	VBN	B-NP
B-Cell	1414	1418	cell	cell	NN	I-NP
I-Cell	1419	1424	lines	line	NNS	I-NP
O	1424	1425	,	,	,	O
O	1426	1433	annexin	annexin	NN	B-NP
O	1434	1436	II	II	CD	I-NP
O	1437	1440	and	and	CC	O
O	1441	1445	beta	beta	NN	B-NP
O	1445	1446	(	(	(	O
O	1446	1447	2	2	CD	B-NP
O	1447	1448	)	)	)	O
O	1448	1449	-	-	HYPH	B-NP
O	1449	1456	tubulin	tubulin	NN	I-NP
O	1457	1467	expression	expression	NN	I-NP
O	1468	1472	were	be	VBD	B-VP
O	1473	1478	found	find	VBN	I-VP
O	1479	1481	to	to	TO	I-VP
O	1482	1484	be	be	VB	I-VP
O	1485	1490	lower	low	JJR	B-ADJP
O	1491	1493	in	in	IN	B-PP
B-Cell	1494	1499	tumor	tumor	NN	B-NP
I-Cell	1500	1505	cells	cell	NNS	I-NP
O	1506	1510	than	than	IN	B-PP
O	1511	1513	in	in	IN	B-PP
O	1514	1522	adjacent	adjacent	JJ	B-NP
O	1523	1529	normal	normal	JJ	I-NP
B-Cell	1530	1540	epithelial	epithelial	JJ	I-NP
I-Cell	1541	1546	cells	cell	NNS	I-NP
O	1547	1549	in	in	IN	B-PP
O	1550	1553	100	100	CD	B-NP
O	1553	1554	%	%	NN	I-NP
O	1555	1558	and	and	CC	O
O	1559	1561	90	90	CD	B-NP
O	1561	1562	%	%	NN	I-NP
O	1563	1565	of	of	IN	B-PP
O	1566	1569	the	the	DT	B-NP
O	1570	1578	patients	patient	NNS	I-NP
O	1578	1579	'	'	POS	B-NP
B-Tissue	1580	1589	specimens	specimen	NNS	I-NP
O	1589	1590	,	,	,	O
O	1591	1603	respectively	respectively	RB	B-ADVP
O	1603	1604	.	.	.	O

O	1605	1612	Finally	Finally	RB	B-ADVP
O	1612	1613	,	,	,	O
O	1614	1621	annexin	annexin	NN	B-NP
O	1622	1624	II	II	CD	I-NP
O	1625	1629	down	down	RB	B-ADVP
O	1629	1630	-	-	HYPH	B-NP
O	1630	1640	regulation	regulation	NN	I-NP
O	1641	1644	was	be	VBD	B-VP
O	1645	1655	positively	positively	RB	I-VP
O	1656	1666	associated	associate	VBN	I-VP
O	1667	1671	with	with	IN	B-PP
B-Multi-tissue_structure	1672	1677	lymph	lymph	NN	B-NP
I-Multi-tissue_structure	1678	1682	node	node	NN	I-NP
O	1683	1693	metastasis	metastasis	NN	I-NP
O	1693	1694	,	,	,	O
O	1695	1705	suggesting	suggest	VBG	B-VP
O	1706	1710	that	that	IN	B-SBAR
O	1711	1713	it	it	PRP	B-NP
O	1714	1717	may	may	MD	B-VP
O	1718	1720	be	be	VB	I-VP
O	1721	1722	a	a	DT	B-NP
O	1723	1733	prognostic	prognostic	JJ	I-NP
O	1734	1740	factor	factor	NN	I-NP
O	1741	1743	in	in	IN	B-PP
B-Cancer	1744	1747	NPC	NPC	NN	B-NP
O	1747	1748	.	.	.	O

O	1749	1760	CONCLUSIONS	CONCLUSIONS	NNS	B-NP
O	1760	1761	:	:	:	O
O	1762	1765	The	The	DT	B-NP
O	1766	1773	results	result	NNS	I-NP
O	1774	1781	suggest	suggest	VBP	B-VP
O	1782	1786	that	that	IN	B-SBAR
O	1787	1794	annexin	annexin	NN	B-NP
O	1795	1797	II	II	CD	I-NP
O	1798	1801	and	and	CC	O
O	1802	1806	beta	beta	NN	B-NP
O	1806	1807	(	(	(	O
O	1807	1808	2	2	CD	B-NP
O	1808	1809	)	)	)	O
O	1809	1810	-	-	HYPH	B-NP
O	1810	1817	tubulin	tubulin	NN	I-NP
O	1818	1822	down	down	RB	B-ADVP
O	1822	1823	-	-	HYPH	B-NP
O	1823	1833	regulation	regulation	NN	I-NP
O	1834	1836	is	be	VBZ	B-VP
O	1837	1846	important	important	JJ	B-ADJP
O	1847	1849	in	in	IN	B-PP
B-Cancer	1850	1853	NPC	NPC	NN	B-NP
O	1854	1863	formation	formation	NN	I-NP
O	1864	1867	and	and	CC	O
O	1868	1871	may	may	MD	B-VP
O	1872	1881	represent	represent	VB	I-VP
O	1882	1891	potential	potential	JJ	B-NP
O	1892	1899	targets	target	NNS	I-NP
O	1900	1903	for	for	IN	B-PP
O	1904	1911	further	further	JJ	B-NP
O	1912	1926	investigations	investigation	NNS	I-NP
O	1926	1927	.	.	.	O

